To achieve this goal, we retrospectively analyzed 229 primary ovarian carcinomas with clinical pathological factors and generated a tissue microarray with archived tissue specimens used for REDD1 expression examination by immunohistochemical staining. The gene discussed is DDIT4; the disease is ovarian carcinoma.